Extracorporeal Membrane Oxygenation Rescue Therapy in a Case of Portopulmonary Hypertension During Liver Transplantation: A Case Report

被引:25
|
作者
Stratta, C. [1 ]
Lavezzo, B. [1 ]
Ballaris, M. A. [1 ]
Panio, A. [1 ]
Crucitti, M. [1 ]
Andruetto, P. [1 ]
Fanelli, V. [2 ]
Marra, W. Grosso [3 ]
Ranieri, M. V. [2 ]
Salizzoni, M. [1 ]
机构
[1] AO Citta Salute & Sci, Ctr Trapianto Fegato, Anestesia & Rianimaz 9, I-10126 Turin, Italy
[2] AO Citta Salute & Sci, Anestesia & Rianimaz 1, I-10126 Turin, Italy
[3] AO Citta Salute & Sci, Cardiol, I-10126 Turin, Italy
关键词
D O I
10.1016/j.transproceed.2013.07.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Portopulmonary hypertension has been reported in 2% to 9% of candidates for liver transplantation (OLT). If it is moderate to severe, it represents a contraindication to the procedure until pulmonary vasodilatative therapy has been optimized. We report the case of a 43-year-old man, scheduled for OLT due to alcoholic cirrhosis with hemosiderosis. His Model for End-Stage Liver Disease was 25 at that time. The preoperative evaluation showed a severe alteration of diffusion (pO(2) 68 mm Hg), without hepatopulmonary syndrome or portopulmonary hypertension (PPH) upon basal and dobutamine stress echocardiography. At the beginning of the OLT the hemodynamic profile showed mean pulmonary artery pressure (mPAP) 38 mm Hg, wedge pressure (WP) 19 mm Hg, cardiac output (CO) 9.1 L/min, pulmonary vascular resistance (PVR) 166 dyne s/cm(5), transpulmonary gradient ('TPG) 19 mm Hg, which lead us to promptly initiate inhaled nitric oxide (iNO) and intravenous epoprostenol 2 to 5 ng/kg/min. Upon graft reperfusion the hemodynamic profile was: mPAP 47 mm Hg, WP 23 mm Hg, CO 14.2 L/min, PVR 135 dyne s/cm(5), TPG 24 mm Hg, and at the end of surgery, mPAP 39 mm Hg, WP 20 mm Hg, CO 10.6 L/min, PVR 123 dyne s/cm(5), TPG 19 mm Hg. On postoperative day (POD) 3, we observed severe worsening of PPH: mPAP 60 mm Hg, WP 10 mm Hg, CO 9.8 L/min, PVR 395 dyne s/cm(5), TPG 50 mm Hg even with maximal pulmonary vasodilatatory therapy (ambrisentan 5 mg, intravenous sildenafil 20 mg x 3 and epoprostenol 22 ng/kg/min, iNO). Severe acute respiratory distress syndrome (ARDS) was presents. Therefore we decided to begin veno-venous extracorporeal membrane oxygenation (v-v ECMO) to correct the hypoxic vasoconstriction. Subsequent weaning from inotropic support with iNO and epoprostenol was possible on POD 7 due to mPAP 42 mm Hg, WP 15 mm Hg, CO 7.9 L/min, PVR 273 dyne s/cm(5), and TPG 27 mm Hg. On POD 11 he was weaned from ECMO due to: mPAP 40 mm Hg, WP 16 mm Hg, CO 6.5 L/min, PVR 295 dyne s/cm(5) and TPG 24 mm Hg. The patient was extubated on POD 17. The cardiac catheterization 1 month after OLT showed: mPAP 28 mm Hg, WP 13 mm Hg, CO 5.4 L/min, PVR 220 dyne s/cm(5) and TPG 15 mm Hg. ECMO rescue therapy in this "extreme" case allowed us to correct hypoxemia responsible for worsening of pulmonary hypertension allowing time to reach the goal of vasodilatatory therapy.
引用
收藏
页码:2774 / 2775
页数:2
相关论文
共 50 条
  • [31] Meropenem pharmacokinetics during extracorporeal membrane oxygenation and continuous haemodialysis: a case report
    Saito, Jumpei
    Shoji, Kensuke
    Oho, Yusuke
    Aoki, Satoshi
    Matsumoto, Shotaro
    Yoshida, Michiko
    Nakamura, Hidefumi
    Kaneko, Yukihiro
    Hayashi, Taiyu
    Yamatani, Akimasa
    Capparelli, Edmund
    Miyairi, Isao
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 651 - 655
  • [32] Hemodynamics guided care during extracorporeal membrane oxygenation (ECMO): a case report
    Al Kanjo, Mohamed
    Giesinger, Regan E.
    Thomas, Brady
    Stanford, Amy H.
    Jackson, Seth
    Bischoff, Adrianne R.
    McNamara, Patrick J.
    JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE, 2024, 13 (02):
  • [33] Pharmacokinetics of Sulfamethoxazole and Trimethoprim During Venovenous Extracorporeal Membrane Oxygenation: A Case Report
    Dhanani, Jayesh A.
    Lipman, Jeffrey
    Pincus, Jason
    Townsend, Shane
    Livermore, Amelia
    Wallis, Steven C.
    Pandey, Saurabh
    Abdul-Aziz, Mohd H.
    Roberts, Jason A.
    PHARMACOTHERAPY, 2020, 40 (07): : 713 - 717
  • [34] Rescue extracorporeal membrane oxygenation therapy in methamphetamine toxicity
    Morrison, Laura K.
    Kromm, J.
    Gaudet, J.
    Zuege, D.
    Button, B.
    Warshawski, F.
    Lucyk, S. N.
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2018, 20 : S14 - S19
  • [35] Extracorporeal membrane oxygenation as acute rescue therapy for negative pressure pulmonary edema in the post anesthesia care unit: A case report
    Augustin, Katrina J.
    Creel-Bulos, Christina M.
    Budhrani, Gaurav F.
    Miller, Casey F.
    Fiza, Babar
    CLINICAL CASE REPORTS, 2023, 11 (07):
  • [37] Extracorporeal Membrane Oxygenation in Pediatric Liver Transplantation
    Ziogas, I. A.
    Johnson, W. R.
    Thurm, C.
    Hall, M.
    Matsuoka, L. K.
    Montenovo, M. I.
    Bacchetta, M. D.
    Godown, J.
    Alexopoulos, S. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1103 - 1103
  • [38] Veno-venous extracorporeal membrane oxygenation rescue for pulmonary hypertension and hypoxemic respiratory failure to obesity hypoventilation syndrome: a case report
    Park, Mi Hwa
    Lee, Man-Jong
    Kim, Jung Soo
    Park, Soo Hyun
    Lee, Jung Hwan
    Kim, Ah Jin
    ANNALS OF PALLIATIVE MEDICINE, 2022, : 3341 - 3345
  • [39] CASE 7-2014 Rescue Therapy With Early Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Bilateral Lung Transplantation
    Farooki, Ali M.
    Bazick-Cuschieri, Heidi
    Gordon, Emily K.
    Lee, James C.
    Cantu, Edward C.
    Augoustides, John G.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 28 (04) : 1126 - 1132
  • [40] Femoral neuropathy following venoarterial-extracorporeal membrane oxygenation therapy: a case report
    Jang, Albert Youngwoo
    Oh, Young Jun
    Lee, Seok In
    Lim, Oh Kyung
    Suh, Soon Yong
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)